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Abstract  
Caspases are a family of cysteine proteases widely known as the principal mediators of the 
apoptotic cell death response, but considerably less so as the contributors to the regulation of 
pathways outside cellular demise. In regards to autophagy, the modulatory roles of caspases have 
only recently begun to be adequately described. In contrast to apoptosis, autophagy promotes cell 
survival by providing energy and nutrients through the lysosomal degradation of cytoplasmic 
constituents. Under basal conditions autophagy and apoptosis cross-regulate each other through 
an elaborate network of interconnections which also includes the interplay between autophagy-
related proteins (ATGs) and caspases. In this review we focus on the effects of this crosstalk at 
the cellular level, as we aim to concentrate the main observations from research conducted so far 
on the fine-tuning of autophagy by caspases. Several members of this protease-family have been 
found to directly interact with key ATGs involved in different tiers across the autophagic 
cascade. Therefore, we firstly outline the core mechanism of macroautophagy in brief. In an 
effort to emphasize the importance of the intricate cross-regulation of ATGs and caspases, we 
also present examples drawn from Drosophila and plant models regarding the contribution of 
autophagy to apoptotic cell death during normal development.  
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AMBRA-1                 Activating-molecule-in-Beclin1-regulated-autophagy-1 
  
AMPK                       AMP-activated-protein-kinase 
 
ATG                           Autophagy-related gene 
 
ATG14L                    ATG14-like 
 
Bcl-2                          B-cell lymphoma 2 
 
DISC                          Death-inducing signalling complex 
 
FADD                        Fas-associated protein with death domain 
 
FIP200                       Focal-adhesion-kinase-family-interacting protein of 200 kD 
 
GABARAP                Gamma-aminobutyric acid receptor-associated protein 
 
GATE-16                   Golgi-associated adenosine triphosphatase enhancer of 16 kD 
 
GTPase                      Guanosine triphosphatase 
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LAMP                        Lysosome-associated membrane glycoprotein 
 
mTOR                       mammalian target-of-rapamycin 
 
MAP1LC3                 Microtubule-associated-proteins 1A/1B light-chain-3 
(or simply LC3) 
 
MOMP                      Mitochondrial outer membrane permeabilization 
 
PCD                           Programmed cell death  
 
PI3K                          Phosphatidylinositol-3 kinase 
 
Raptor                        Regulatory-associated-protein-of-mTOR 
 
RIPK1                        Receptor-interacting serine/threonine-protein kinase 1 
 
t-SNARE                    target-Soluble N-ethylmaleimide-sensitive factor attachment protein         
receptor 
 
ULK                           Uncoordinated (UNC) 51-like kinase 
 
UVRAG                     UV-radiation resistance-associated gene 
 
VPS34                        Vacuolar-protein-sorting-34 
Facts 
• Caspases have been shown to directly interact with core autophagy proteins 
 
• Autophagy is implicated in many physiological and pathological processes, where apoptosis is 
also involved 
Open Questions 
• Does control of autophagy by caspases represent a central or a supplementary mode of regulation 
of this pathway? 
 
• Is caspase activation required to control autophagy? 
  
• To what extent do caspases affect autophagy and how exactly their effects on the pathway vary 
across different contexts? 
4 
 
Introduction 
Apoptosis is the tightly controlled process for an orderly executed cell death, and its key mediators, 
the caspases (Cysteine-dependent aspartate-specific proteases), are known for their indispensable 
part in the cascade. They exist predominantly as inactive precursors within cells,  activated 
frequently by oligomerization, cleavage of regulatory pro-domains, and/or dissociation from 
endogenous inhibitors [1]–[3]. In mammals, the ten major caspases (of the 14 characterized so far) 
can be roughly classified based on their primary apoptotic role, as initiators (caspase-2,-8,-9, and -
10), or executioners (caspase-3, -6, and -7) [1]–[3]. The third group consists of inflammatory 
caspases (caspase-1, -4, and -5) which are largely involved in “pyroptosis”; a prominent mode of 
PCD during host-pathogen interaction, which also involves the immune system response [1]–[3].  
While there is still a degree of dispute over the apoptotic roles of inflammatory caspases, the 
members comprising the other two groups have well-documented functions in the mediation of the 
apoptotic response [1]–[5].  Although caspase functions have been a commonly pursued research 
subject for decades, new properties are continuously attributed to these molecules [3], [6]. For 
instance, caspases owe half their name to their highly site-specific cleavage of their substrates on 
aspartate-containing recognition sites. Nevertheless, they have been recently reported to cleave their 
targets almost as efficiently on motifs bearing glutamate or phosphoserine in place of aspartate [6]. 
Despite their initial discovery as cellular assassins, the exponential increase of evidence that 
followed in support of their additional non-apoptotic functions has served to view caspases under a 
different scope; that of agents with many faces, contributing to the regulation of cellular processes 
that often function complimentary, or even oppositely to apoptosis [3], [7], [8]. One such example 
can be gleaned from their involvement in autophagy, a cellular process intricately connected with 
apoptosis; so much that often perturbations in one pathway considerably impact the other [9]–[13].  
Autophagy (from the Greek for “self-eating”), was  coined in 1963 by Nobel laureate C. de Duve 
[14]. 30 years later, the seminal work conducted by Y. Ohsumi in describing the core machinery of 
the process in yeast would in turn lead to his award with the 2016 Nobel Prize, in recognition of the 
pathways’ cardinal role in the well-being of cells [15], [16]. Since the first description of the 
process, autophagy is further subdivided nowadays into three types (macroautophagy, 
microautophagy, and chaperone-mediated autophagy) [17]–[19], of which macroautophagy is the 
most well-studied and in many texts including this review, the term is simply referred to as 
autophagy. The process is responsible for the recycling of intracellular constituents, in which a 
portion of the cytosol is sequestered by isolation membranes. This leads to the formation of a 
double-membrane-layered organelle called the autophagosome, which subsequently fuses with a 
lysosome to create an autolysosome, a structure with a single limiting membrane wherein its 
contents are degraded. The residual materials are then recycled back to the cytosol for effective use 
by the cell [20]. In this manner an assortment of intracellular residents including protein aggregates 
[21], [22], damaged organelles [23], [24], and invading pathogens [25]–[27], as well as caspases 
[28], [29] can be effectively cleared from the cytosolic environment. Therefore, autophagy is 
primarily regarded as a pro-survival mechanism and is triggered in response to a wide array of life-
threating stimuli. The nature of its function places the pathway at the kernel of many physiological 
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settings where apoptosis is also involved [30]. Their complex interplay is particularly highlighted 
during physiological processes such as developmental remodeling and cell differentiation [31], as 
well as aging [32]. Moreover, perturbations which impair the efficient removal of protein 
aggregates and cytotoxic oligomers by autophagy have been reported in a range of 
neurodegenerative diseases including Alzheimer’s [33] and Parkinson’s [34]. Additionally, it is 
posited that some cancer cells can utilize autophagy as a means to prolong their survival [35], [36].  
Similarly to apoptosis, progression of autophagy follows a tightly supervised outline of events. 
Many steps in this cascade are controlled by the interactions of several ATGs with non-autophagy 
exclusive regulators including caspases [3], [9], [10], [13], [37]. In order to gain a clearer overview 
of the ways caspases can associate with ATGs and modulate autophagy, we firstly describe the 
stepwise assembly of the autophagic machinery in mammalian systems. Due to space limitations the 
process is presented in great summary. 
Overview of the autophagy cascade  
Initiation 
The ULK-complex is regarded as the apical initiator of autophagy in mammals [38], [39]. Its key 
kinase ULK is the functional homologue of Atg1, with at least four known members in the family 
(ULK1-4) [40]. ULK1 and ULK2 are the most frequently studied in autophagy investigations and 
they are found to form distinct ULK-complexes within cells [39], mainly due to their different 
binding affinity for another prominent member of the ULK-complex; ATG13 [38]–[40]. Because of 
their characterized role in autophagy it is these two members that are being implied hereafter when 
mentioning either ULK or ULK-complex, unless explicitly specified. Together with ULK and 
ATG13, the core of the ULK-complex is further complemented by ATG101 [41] and the scaffold 
protein FIP200 [42], [43]. FIP200 is arguably the functional homolog of yeast Atg17 and binds 
ULK, indirectly promoting its kinase activity [38]. ATG13 facilitates the interaction between ULK 
and FIP200 and preferentially binds ULK1 over ULK2 [38]–[40].  
 
Activity of the ULK-complex is in turn modulated further upstream by two Ser/Thr kinases, mTOR 
1 and 2 [44], [45]. In an analogous fashion to ULK, these kinases associate with several different 
binding partners in distinct mTOR complexes (mTORC) with respectively distinct properties and 
signaling pathways [44], [45]. An example of the differential response of each complex related also 
to autophagy, is that activity of mTORC2 remains unaffected by treatment of cells with the 
autophagy inducer rapamycin, in contrast to mTORC1 [46]. mTORC2 interacts with the rapamycin-
insensitive-companion-of-mTOR (Rictor) in place of Raptor [46]; the binding partner of 
mTORC1[44]–[46]. While they both regulate autophagy, the mTORC2-signalling cascade is still 
poorly defined therefore, the more well-characterized mTORC1-dependent pathway is often utilized 
to induce autophagy instead [44]–[46].  
Under fed conditions, mTORC1 binds to and inhibits ULK [47]. In contrast, depletion of 
intracellular amino-acid levels following starvation results in the upregulation of energy level-
dependent sensors such as AMPK, which phosphorylates and aids in the dissociation of mTORC 
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from ULK [47], [48]. In addition to other post-translational modifications, ULK further activates 
ATG13, FIP200 and ATG101within the complex [38], [49]. The fully-engaged ULK-complex then 
translocates to the membrane compartment of phagophore assembly together with the class-III PI3K 
complex (PI3KC-III); the leading multi-protein structure of the next stage [38], [49]. A schematic 
representation of the step-wise progression of the autophagic cascade in mammalian systems after 
mTOR inhibition is given in Figure 1. 
 
Phagophore nucleation and expansion 
The lipid kinase VPS34, its regulatory subunit p150, and Beclin-1 (the orthologue of yeas Atg6) are 
the main components of PI3KC-III, which is essential through the steps of phagophore formation to 
its maturation to a complete autophagosome [43], [50]. Other important co-regulators of the 
complex include ATG14L, AMBRA-1 and UVRAG [50]. ATG14L and UVRAG compete for their 
binding of Beclin-1 and form separate PI3K-III complexes, which are respectively required in 
autophagosome biogenesis and in their maturation and fusion with lysosomes [20], [50], [51]. 
Beclin-1 is of particular interest as it sits at the crossroads between autophagy and apoptosis. As a 
Bcl-2-homology (BH)-3 domain only protein it interacts with BH3-domains of other Bcl-2 family 
proteins and  is often bound inert to the anti-apoptotic Bcl-2 or Bcl-XL proteins at the outer 
mitochondrial membrane [50]. Upon initialization of autophagy, Beclin-1 undergoes 
phosphorylation and ubiquitination as well as associating with the ULK1-activated scaffold 
AMBRA-1 [50], [52]. These changes favour the uncoupling of Beclin-1 from Bcl-2; the freed 
protein in turn triggers the formation of the PI3K-III-complex by binding and switching-on VPS34 
[50], [52]. The upregulated PI3KC-III generates a local pool of PI3-phosphate (PI3P) at the 
phagophore nucleation site, which serves as a beacon that attracts additional PI3P-sensing 
phospholipid effectors and ATG proteins on the scene [50]. Elongation of the nascent organelle 
depends on the constant incorporation of membrane material to its expanding body [43]. Among the 
many crucial modulators of this elaborate step, two transmembrane proteins, ATG9 and vacuolar-
membrane-protein-1 (VMP1) often stand out due to their respective roles. VMP1 tethers PI3KC-III 
to the developing surface of the phagophore by binding to Beclin-1 in the complex. ATG9 is the 
only ATG member characterized so far, capable of shuttling between cytosolic compartments and 
transferring membrane cargo to the nascent autophagosome [20]. 
 
The mammalian Atg8 family consists of 3 subfamilies: LC3, GABARAP and GATE-16; all 
containing members with clarified or lesser known roles in autophagy [53], [54]. Of these, the 
variants of the LC3-subfamily (LC3A, LC3B, LC3C) and namely LC3B (hereafter LC3), are 
routinely used as markers in assays monitoring autophagosome formation [53], [54]. LC3 and the 
E3-ligase ATG12 are two ubiquitin-like proteins necessary for autophagosome expansion and 
closure and are recruited to the membrane site along with their associated ubiquitin-like conjugation 
systems [55], [56]. ATG7 activates ATG12 and ATG10 conjugates it to ATG5 [9], [50], [55]. The 
resulting ATG12-ATG5 heterodimer then binds ATG16L1, altogether completing the core of the 
ATG16L1 complex [9], [50], [55]. LC3 is cleaved by the cysteine protease ATG4B, yielding LC3-I, 
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which is subsequently transferred by ATG7 to the inner and outer membrane of the expanding 
phagophore [57]–[59]. There, LC3-I is passed over to ATG3 and by the localized operations of the 
PI3K-III and ATG16L1 complexes it is lipidated to LC3-II and anchored to the autophagosomal 
membrane [57]–[59].  
 
Maturation and fusion with lysosomes 
During fusion of the mature autophagosome with a lysosome, the ATG16L1-complex dissociates 
from the vesicle and ATG4B removes the cytosolic fraction of LC3-II [43], [57], [59]. 
A t-SNARE complex involving several syntaxins and ATG14L generally prime the cargo-bearing 
autophagosome for the fusion step with the lysosome [51]. Other reports suggest that an 
intermediate autophagosome-endosome fusion step might occur, thereby providing the factors 
necessary for the ensuing lysosomal fusion [60].  Acidification and further maturation to fully 
fledged autolysosomes is mediated with the aid of small GTPases of the Rab family, together with 
the lysosome-associated-membrane glycoproteins LAMP1 and LAMP2 [55], [61].  
Table 1 summarizes the core ATG and co-regulator proteins discussed here, along with their 
position in the autophagic cascade and their function. 
 
Caspases impact on autophagy 
Autophagy and apoptosis are interlocked in an extensive crosstalk with each other, therefore it may 
not be surprising that many ATGs are recognized and cleaved by caspases [10], [37], [62], [63]. In 
most cases, interaction of the caspase with the ATG protein leads to abrogation of the autophagic 
function of the latter, and the homeostatic balance shifts in favor of an apoptotic profile (Figure 2) 
[11], [52], [64]. This is generally regarded as a commitment of dying cells to an apoptotic PCD by 
progressively shutting down other functions, including autophagy. Nevertheless, caspase-mediated 
cleavage of ATGs does not always result in idle waste products; instead several ATG-fragments 
have been shown to acquire new properties, which can differ greatly from those of their initial full-
size isoforms and consequently affect apoptosis and autophagy in numerous ways [65], [66]. On the 
other hand caspases have also been found to promote autophagy under certain contexts [66]–[68]. 
The findings from the existing literature presented below are split between the initiator and the 
effector caspase groups, pertaining to their main role in apoptosis (as shown in Table 2).  
Initiator Caspases 
 
Caspase-1 is primarily involved in the maturation of the pro-inflammatory cytokines interleukin-
1B/interleukin-18 during oxidative stress in immune cells and endothelial cells [67], [69]. 
Additionally, a role of caspase-1 in facilitation of cytoprotective autophagy has been suggested 
during hypoxia-induced mitochondrial stress [67]. In hepatocytes of casp-1 -/- mice levels of the 
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common autophagy markers LC3 and Beclin-1 were found to be decreased compared to wild-type 
(WT) [67]. When Beclin-1 was overexpressed in these cells the group reported that impaired 
autophagic clearance of damaged mitochondria was restored to WT rates [67]. It was therefore 
suggested that aside from its role in immune cells, caspase-1 in murine hepatocytes appears to favor 
autophagy and clearance of damaged mitochondria after redox stress by activating LC3 and Beclin-
1 through an as-of-yet undefined mechanism [67].  
Caspase-2 is the most evolutionary conserved member of the caspase family and possess features 
of both initiator and effector caspases [70]. It conveys the apoptotic signal chiefly after stimuli such 
as oxidative stress [71], DNA damage [70], heat shock [72] and cytoskeleton disruption [73]. In 
regards to its involvement in autophagy, under normal conditions caspase-2 is evidently a negative 
regulator of the process, as supported by results derived from mouse embryonic fibroblasts (MEFs) 
[74] and young adult mouse cortical neurons [71]. In both murine models, casp2 knock-down at an 
early-stage lead to inhibition of apoptosis and mobilization of cytoprotective autophagy, particularly 
when the initial death-inducing stimulus was delivered either via heat shock or mitochondrial 
oxidative stress [71], [74].  
While the exact mechanism of caspase-2-dependent modulation of autophagy remains to be fully 
delineated, it seemingly involves control of intracellular levels of reactive oxygen species by 
caspase-2 [71], [74]. Loss of caspase-2 favors the accumulation of oxygen radicals, which spark a 
cascade of events culminating in the concomitant downregulation of autophagy suppressors such as 
TORC and activation of pro-autophagy mediators including AMPK [74].  
Caspase-8 is commonly upregulated during the extrinsic apoptotic cascade, shortly after activation 
of death receptors expressed at the cell-surface [2], [75]. DISC is the multi-protein signaling 
platform assembled on the scene, whereupon the inactive precursor pro-caspase-8 dimerizes and 
cleaves itself and subsequently released in its functional state to the cytoplasm, triggering 
upregulation of its effector caspases  [75]–[77].  
In addition to its conventional activation pathway, caspase-8 maturation has been reported even in 
the absence of DISC [78], [79]. When formation of this complex is inhibited, autophagy seemingly 
takes over, either as a death-escaping mechanism or as an alternative route for caspase-8 activation 
[78], [79]. Pro-caspase-8 can be localized to autophagosomes via the ATG8/LC3-interacting 
molecule p62 [80]. This is an adapter protein which binds poly-ubiquitinated (polyU) protein 
aggregates and targets them for sequestration at the site of autophagosome formation [81]. In this 
case, the autophagosomal surface may provide a platform where polyU pro-caspase-8 oligomers can 
be brought in close proximity with each other, thereby facilitating their interaction and maturation 
to caspase-8 dimers [80], [82], [83]. Conversely, it has also been proposed that sequestration of 
caspase-8 or its dormant precursor to the autophagosome may be a method utilized at least by Bax-
/- Hct116 colon carcinoma cells to promote their survival instead [28]. It is important to note that 
these cells develop a resistance to apoptotic stimuli, despite having a fully functional DISC capable 
of switching on caspase-8 [28]. However, active caspase-8 and its inactive pro-form can still be 
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targeted and extensively retained at the autophagosome where they are eventually degraded along 
with the rest of the autophagosomal cargo within the ensuing autolysosome [28]. Since there is not 
enough caspase-8 to adequately propagate the cell death signal, cancer cells become increasingly 
unresponsive to apoptotic stimuli [28]. To rescue caspase-8 from autophagic degradation and re-
sensitize cancer cells to apoptotic cell death, a viable option in this instance is to inhibit 
autophagosome formation [28]. As the above examples illustrate, the contradictory functions of the 
autophagosomal surface in regards to caspase-8 activity should be taken into account in 
investigative approaches to cancer-treatment by manipulating autophagy. As this effect seems to be 
context-dependent it is paramount to find the right balance between promoting targeting of the 
protease to the developing phagophore and inhibiting autophagy, in order to re-establish an 
organized apoptotic dismantling of different type of tumor cells. There are already reports where the 
ability of p62 to promote caspase-8 activation at the autophagosomal membrane has been 
successfully exploited to render cancerous cell-lines responsive to further pharmacological 
treatment [83], [84].  
Moreover, functional caspase-8 has been shown to prevent autophagy from over activation [85]. In 
rapidly proliferating T-cells lacking either the DISC-adapter protein FADD or caspase-8, the 
autophagic response was initially mounted in order to provide the necessary energy to support their 
proliferation [85]. However, the process quickly became hyperactive and led to cell death with 
necroptotic features such as the upregulation of the Ser/Thr kinase RIPK1 [85]. This specific kinase 
as well as pro-caspase-8, associate with the ATG16L1 complex, which apart from its 
autophagosome-expanding role, has been quite interestingly shown to also serve as an auxiliary 
scaffold to DISC assembly [80], [85]. In WT T-cells, ATG5 is observed to interact with FADD, 
which also binds both pro-caspase-8 and RIPK1 [85]. The association of ATG5 with FADD can 
thereby promote DISC formation and maturation of pro-caspase-8 to active caspase-8 in a manner 
additionally involving the autophagosome-forming machinery [85]. The caspase can then cleave 
RIPK1, as part of a negative feedback loop to prevent excessive autophagy [85]. In the absence of 
either FADD or caspase-8, RIPK1 remains on and perpetuates the autophagic response, eventually 
resulting in necroptotic cell death [85]. RIPK1 also augmented autophagy in lung, bladder and 
prostate cancer cell-lines after stimulation of the external apoptotic pathway by the TNF-related 
apoptosis-inducing ligand (TRAIL) [86]. Based on these findings, caspase-8 and RIPK1 have 
emerged as valuable drugable targets to manipulate the balance between autophagy and apoptosis in 
under certain frameworks, in order to stall proliferation and induce recession of malignant tumors 
[85], [86].  
The role of caspase-8 in modulating autophagy is further complemented by its interactions with 
ATG3, ATG5 and Beclin-1, which are all reportedly prone to cleavage by the protease in vitro [87], 
[88]. Following death-receptor activation in several cancer-derived cell lines, the subsequent 
downregulation of autophagic flux has been partly attributed to caspase-8-dependent cleavage of 
these autophagic proteins [50], [87], [88]. A peculiar yet noteworthy finding is that the processing 
of Beclin-1 by many initiator and effector caspases often returns a C-terminal fragment which in a 
10 
 
starvation-induced setting displays increased pro-apoptotic properties [50], [65]. It has been long 
accepted that both the extrinsic and intrinsic apoptotic pathway converge at the mitochondrial pro- 
and anti-apoptotic Bcl-2 proteins, which control the rate of cytochrome-c release [76]. The 
truncated Beclin-1 fragment has been observed to also localize to mitochondria and further promote 
MOMP and the release of pro-apoptotic factors to the cytosol, consequently amplifying the 
apoptotic response [50], [65]. The processing of ATG3 by caspase-8 was shown to effectively 
inhibit assembly of the autophagic machinery at an early stage and promote apoptosis [88] .The 
caspase-recognition site on ATG3 has been mapped in the region between amino-acids 166-169 
which contains an evolutionary conserved LETD motif that is widely recognized by many caspases 
[88].  
Caspase 9 is set in motion following cytochrome c-mediated assembly of the Apoptotic-protease-
activating factor-1 (Apaf1)-apoptosome during the intrinsic apoptotic cascade [2], [89]. In regards 
to autophagic proteins being substrates for the protease, in several tumor cells caspase 9 cleaves and 
inactivates to a certain degree ATG5 and Beclin-1 [87], [90]. Another additional connection of the 
protease with autophagy has been proposed following consecutive observations on the MCF-7 
breast cancer cell-line [91]. In this cell-line, the non-steroidal anti-inflammatory drug FR122047 
(FR) is used to induce cell death via the extrinsic apoptotic signalling [91]. When MCF-7 cells 
deficient for caspase-9 were treated with FR, their susceptibility to cellular demise was increased, 
with a concomitant decrease in autophagic flux [91]. The authors postulated that caspase-9 possibly 
contributes to upregulation of cytoprotective autophagy by mediating proper acidification of 
lysosomes and the acid-dependent functions of cathepsins [91]. As a result, caspase-9-deficient 
MC7-cells appear to respond more positively to treatment with FR, due to their inability to mount a 
proper autophagic response [91].  
Building on these findings, the mechanism by which caspase-9 exerts this peculiar effect on 
autophagy was later investigated in more detail. It was discovered in tumor cell-lines as well as 
MEFs with inducible knock-outs for an array of  ATGs, that caspase-9 forms a stable complex with 
ATG7 [68]. This interaction does not result in cleavage of ATG7 but conversely the caspase-9-
ATG7 complex is more efficient at binding and priming LC3, resulting in a corresponding increase 
of developing autophagosomes [68]. This is partly due to the fact that catalytic activity of caspase-9 
while bound to ATG7 is abolished, leaving ATG7 affinity for LC3 unobstructed, thus leading the 
authors to posit that this mechanism may be utilized by several tumor cells in order to prolong their 
survival [68].  
Caspase 10 is turned on in an analogous manner to caspase-8 during the extrinsic apoptotic 
pathway. In addition to its reported cleavage of ATG5 and Beclin-1 [50], [87], [90], caspase- 10 has 
also been discovered to modulate autophagic flux by processing Bcl-2-associated transcription 
factor 1 (BCLAF1) in a myeloma cell-line [92]. BCLAF1 is a known inducer of autophagy capable 
of indirectly activating Beclin-1 by antagonistically competing for their binding site at Bcl-2 [92]. 
This finding was the result of series of experiments utilizing RNA-interference to knock down an 
array of target proteins required for cell survival, identifying BCLAF-1 to be a substrate of caspase-
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10 [92]. Proteolytic cleavage of BCLAF1 by caspase-10 abolished its function and therefore Beclin-
1 remained tethered to Bcl-2 [92]. By effectively exploiting this mechanism, myeloma cells despite 
their requirement for a degree of background autophagy, seemingly ensure their survival by keeping 
the process in check and consequently escape demise [92].  
Effector Caspases 
 
Caspase-3, along with caspases -6 and -7, is the principal effector caspase whose role in autophagy 
regulation has been investigated the most. The first study to suggest a role of mammalian caspase-3 
in autophagy utilized TRAIL-induced apoptosis in HeLa cells, during which Beclin-1 was cleaved 
in a caspase-dependent manner [90]. The research group disclosed that proteolytic processing of 
Beclin-1 by caspase-3 was found to be sufficient in significantly impairing autophagic flux when an 
apoptotic-inducing stimulus was applied [90]. In contrast either overexpression of Beclin-1 in this 
cell-line or introduction of a non-cleavable mutant effectively inhibited TRAIL-induced cell death 
in this cell line [90].  
Two caspase-3-cleavage sites of Beclin-1 have been since identified on positions 124 and 149 [64]. 
Moreover, in murine bone marrow cells that underwent prolonged starvation, the initial autophagic 
response gradually shifted towards apoptosis [65]. During this transition stage Beclin-1 was shown 
to be cleaved by caspase-3, generating a C-terminal fragment that enhanced cell-death by the 
mechanism already mentioned [65]. ATG5 has also been proposed to be prone to cleavage by 
caspase-3, consequently contributing to autophagy downregulation [87].  
Other studies argue that caspase-3 in nutrient-deprived human endothelial cells is able to aid  
towards the export of maturing LC3-containing autophagic vesicles through the plasma membrane, 
promoting cell-volume shrinkage, which is an indicative apoptotic marker [93], [94].  
An isoform of the ATG4 protease, ATG4D, is another prominent substrate for caspase-3 processing 
[95]. Cleavage of ATG4D by caspase-3 has been shown to occur at the N-terminal DEVD63K motif, 
which is a common caspase-cleavage site [66]. This action returns a truncated product (ΔN63K-
ATG4D) with enhanced lipidation activity on the Atg8-related family member, GABARAP-L1 
[66], [95]. The cleaved isoform was found to promote autophagy when it was the product of 
caspase-3 processing of endogenous ATG4D, but when overexpressed,  ΔN63K-ATG4D was 
shown to enhance apoptosis instead [95]. This cytotoxic effect is possibly due to the combination of 
increased levels of ΔN63K-ATG4D and its enhanced affinity for damaged mitochondria where it 
augments with a currently undefined mechanism, MOMP and the subsequent release of pro-
apoptotic factors in the cytosol [66].  
Furthermore, AMBRA-1, which favors Beclin-1 binding to PI3KC-III, has being identified as an 
additional target for caspase-3-processing during apoptosis in vitro [52].  When AMBRA-1 was 
inactivated due to proteolytic cleavage by caspase-3, Beclin-1 consequently failed to couple 
effectively to PI3KC-III and autophagosome formation was inhibited as a net result [52].  
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Autophagy was thereby halted in an AMBRA-1-dependent fashion, favoring the progress of the 
apoptotic cascade [52].  
Caspase 6 impact on autophagy progression has been suggested, along with other caspases, based 
on observations from cancer-derived cell cultures [87], [90]. In melanoma-derived cell-lines 
subjected to starvation and TRAIL-induced cell death, caspase-6 was shown to exacerbate 
degradation of Beclin-1 and ATG5, further inhibiting autophagy and shifting the balance in favor of 
an apoptotic response in these cells [87].  
Moreover, an in vitro screening for identifying protease regulators of ATG proteins in mammalian 
cells showed that also ATG3 and p62 are potential substrates for caspase-6 processing [62]. When  
ATG3 is cleaved by the effector caspase, autophagy is subsequently downregulated, possibly due to 
inhibition of phagophore formation [62]. However, the exact reason why the pathway is inhibited as 
a result of p62 loss is yet unclear. A possible explanation as proposed by the authors might lie in the 
role of p62 as a promoter of autophagy by targeting LC3 and polyU-aggregates at the site of 
autophagosome formation [82], [96]. Its loss due to caspase-6 cleavage may therefore result in the 
less efficient recruitment of LC3 and polyU-cargo to the autophagosome, inevitably posing a 
setback in autophagy progression [62]. In a potential extension of this argument, in several settings 
p62 can modulate caspase-8 function by targeting its polyU-precursor to the autophagosome during 
apoptosis upregulation, as already mentioned [82], [83]. Caspase-8 then activates downstream 
executioners such as caspase-6, thereby enhancing the apoptotic response [1]. As such, it may be 
posited that in those same settings caspase-6 may potentially cleave p62 as part of a negative 
feedback loop that further prohibits the recruitment of LC3 and polyU-cargo to autophagosomes. 
No matter how tempting these explanations might be, due to its role p62 is involved in many 
cellular processes. As such its observed impact on autophagy because of its loss may just as likely 
be more indirect, through other p62-dependent cascades being affected, which additionally fine-tune 
autophagy. The precise function/s of p62 in autophagy is a subject still under intense scrutiny. 
Caspase-7 is the third member of the staple executioner caspase trio and the lesser known in 
regards to its impact on the autophagic pathway. Under nutrient scarcity, Beclin-1 is reportedly 
targeted directly by caspase-7 during apoptosis, which is preceded by autophagy upregulation [65]. 
A study demonstrated the ability of caspase-7 to bind and cleave a mutant of ATG16L1 
(mutATG16L1) in cells from knock-in murine models bearing one amino-acid substitution on 
position 300 of ATG16L1, which turns threonine to alanine [97]. Binding affinity of caspase-7 was 
greater for mutATG16L1 compared to WT ATG16L1 [97]. In humans, this single coding 
polymorphism is arguably liked to increased risk for developing Crohn’s disease [97], and caspase-
7 binding to mutATG16L1 was correlated to an observed decrease of autophagy in response to 
pathogen-infection [97]. The group concluded that, even though the exact mechanism warrants 
further investigation, compromised cytoprotective autophagy in this context appears to be 
associated with increased bacterial load, further disrupting cellular integrity and potentially 
contributing to the disease manifesting in cells [97].  
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Functional conservation of the caspase-autophagy cross-regulation and its importance in 
developmental cell death 
The role of autophagy as a cell death modality has sparked increased controversy among 
researchers. “Autophagic cell death” (ACD), also known as type-II PCD, refers to a particular 
phenotype of cellular demise whereupon an overabundance of autophagic vesicles is evident in 
dying cells, giving them a characteristic vacuolated appearance [12], [98]. However, researchers 
agree that, since it is often difficult to distinguish whether autophagy is a causal or an auxiliary 
phenomenon of cell death, the line between “cell death by autophagy” and “cell death with 
autophagy” must be drawn as clearly as possible in functional studies [99], [100]. There are 
excellent reviews available that deal in greater depth with this condition-specific duality of the 
pathway [12], [101]. 
The fruit fly Drosophila has provided substantial evidence favoring the contribution of autophagy 
to cell or tissue degradation, especially during developmental remodeling [102], [103]. Upon 
salivary gland removal in late larval stages, autophagy functions in parallel with caspase-dependent 
apoptosis to degrade the larval tissue [104]. Mutations of single key Atg genes or inhibition of the 
Drosophila initiator caspase Dronc, severely delay this degradation step [104]. Restoring 
expression of Atg-1 in these cells re-vitalizes the autophagic response and leads to premature cell 
death in a caspase-independent fashion [104]. 
Furthermore, upon larvae to pupae transition stage, midgut cells of the intestine are disposed in a 
manner predominantly driven by autophagy and secondarily by apoptosis [105], [106]. In this 
setting, inhibition of core Atgs has been observed to negatively influence the rate of midgut cell 
degradation, which in contrast to salivary glands is not delayed further by inhibiting individual 
caspases or by using the pan-caspase inhibitor p35 [104], [106].  
In addition to these examples, Drosophila and mammalian oogenesis also share the degradation of 
supporting nurse cells by PCD, which promotes the growth and maturation of oocytes [107]–[109]. 
In nurse cells the effector caspase Dcp-1 (the Drosophila homolog to caspase-3) and its upstream 
inhibitor of apoptosis dBruce were first observed to regulate autophagic flux, which contributed in 
turn to ovarian PCD [110]. Shortly after, it was shown that activation of PCD relied on the apical 
degradation of dBruce by autophagy, which enhanced Dcp-1 function and autophagy upregulation 
in a positive feedback loop, involving Dcp-1 translocation to mitochondria and its localized 
suppression of a recently identified autophagy-inhibitor [108], [111]. Nevertheless, since the 
effective removal of nurse cells has also been reported even when inhibiting both apoptosis and 
autophagy [112], the conditions under which autophagy functions as or contributes to death-
mediating pathways require further elucidation. 
Finally, in plants, fungi and protists, the caspase-like counterparts known as metacaspases are 
essential to plant PCD, particularly under several stress conditions [113]. However, despite their 
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functional homology as well as some sequence similarities with caspases, metacaspases also bear 
striking differences such as cleaving of their substrates after an arginine or lysine residue, instead of 
aspartate [113], [114]. Their involvement in controlling autophagic flux has been documented in 
vacuolar PCD (vPCD) during plant development [113], [115], [116] where activity of type II-
metacaspase (mcII-Pa) was detected prior to vPCD of embryo-supporting tissue [116]. Metacaspase 
and autophagy upregulation was measured following the knock-down of either core Atgs or mcII-Pa 
respectively [115]. It was subsequently reported that mcII-Pa may operate as an upstream positive 
mediator of autophagic flux, by potentially cleaving or interacting in some other way with an as of 
yet uncharacterized suppressor of autophagy in plants [115], [116].  
 
Conclusions 
Although on many occasions caspases stay true to their role as death-propagators that cleave and 
inactivate their target substrates, under specific circumstances they can seemingly forego their 
primary directive and contribute instead to cell survival by polarizing cells towards autophagy. The 
precise mechanics by which a number of caspases manage to promote autophagy remain largely 
unknown. It is important to note that unless the initial stress-inducing stimulus is overwhelming, 
most cells will firstly aim to survive by mounting an autophagic response, before resorting to 
suicide [9], [10], [13]. In spite of its cytoprotective role, if autophagy progresses unimpeded over 
and above an especial threshold, it can lead to upregulation of cell-death markers, and activation of 
the apoptotic machinery or other cell death modalities if apoptosis is impaired [13]. In this regard, 
some caspases can evidently act as molecular brakes by constitutively degrading ATGs and other 
autophagy promoters as a means to keep the process from reaching a point of no return, past which 
the cellular suicide machineries are turned on. This is particularly exemplified with apical caspase-
8, as it switches off the potent autophagy-enhancer RIPK1, therefore keeping the autophagic flux in 
check [85]. In contrast to this, the non-apoptotic role of caspase-9 appears to be mostly a matter of 
its limited availability due to its association with ATG7 in a complex, which nonetheless favors 
autophagy upregulation [68]. Furthermore, the differential proteolytic cleavage of autophagy-
proteins by initiator and executioner caspases can result in fragments, which display either pro-
apoptotic or pro-autophagic properties as discussed for Beclin-1 and ATG4D respectively.  
The gradual unveiling of hidden functions for known regulatory proteins births new questions at an 
exponential rate. Is caspase-control of autophagy an essential mode for managing this pathway? 
Caspase involvement stands out particularly in apoptosis-inducing settings. As autophagy is a 
highly elaborate pathway, many signaling networks converge to regulate the process, therefore it is 
reasonable to expect that depending on setting, certain networks may impact the pathway more 
prominently than others. Do the caspase precursors have any type of control over the autophagic 
cascade? Perhaps. As the modulatory effects of pro-caspases in relation to autophagy is a largely 
unexplored avenue, it remains to be seen if and to what extent they can potentially affect the 
process. On the other hand, as already reported for pro-caspase-8, the autophagic machinery can be 
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indispensable as an alternative path to the maturation of the protease in conditions where the 
conventional mode of activation is blocked [78], [79]. Whether other cell-death proteases can be 
upregulated in a similar manner is a question in a long list of questions which warrant further 
investigation in order to decipher the underlying interconnections behind the mutual crosstalk of 
autophagy and apoptosis. Since caspases have been known to contribute to processes such as cell-
proliferation and differentiation, which are starkly contradictory to apoptosis [3], [117], [118], it is 
entirely possible that these misunderstood hitmen may have additional and more extensive roles in 
autophagy awaiting discovery. Taking all the presented findings into account, the primary 
conclusions of the review are that caspases can directly interact with known ATGs and 
consequently affect autophagy in a number of ways. In the majority of cases autophagy is 
downregulated in favour of apoptosis. Interestingly enough, apical caspases -1, -8, and -9, as well as 
executioner caspase-3 have been found to promote autophagy on occasions. Overall, the net effect 
on autophagy due to caspase-ATG interactions appears to rely heavily on context, and further work 
is required to delineate the complex relationships between autophagic proteins and cell death 
proteases in health and disease. 
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Figure legends 
 
Figure 1  
Overview of the autophagy mechanism in mammalian cells.  
The proteins are grouped according to their position in the cascade. “Core” contains within its 
boundaries the key proteins that make up each complex. A. Initiation. Upon nutrient withdrawal 
AMPK phosphorylates mTORC1, thereby lifting its inhibitory effect on ULK, and allowing the 
initiation complex to be activated. ULK phosphorylates AMBRA-1, which subsequently severs 
the binding between Beclin-1 and Bcl-2 proteins, and facilitates Beclin-1 interaction with p150 
and VPS34 in the PI3K-III-complex. UVRAG and ATG14L differentially bind to form distinct 
PI3K-III-complex populations within cells, while AMBRA-1 also interacts with the PI3K-III-
complex. B. Nucleation. The ULK- and PI3K-III- complexes then translocate to the nascent 
phagophore site with the aid of ATG9 and VMP1, where the localized generation of PI3P leads 
to the recruitment of additional effectors, and the formation of the initial isolation membrane (not 
shown). C. Elongation. Shortly after autophagy upregulation, ATG7 and ATG10 are activated 
and instigate the formation of the ATG5-ATG12 dimer which then binds ATG16L1 to create the 
ATG16L1 elongation complex. ATG7 also oversees together with ATG4B and ATG3 the 
cleavage and lipidation of LC3 to LC3-I and then LC3-II, which is bound to the inner and outer 
membrane of the forming phagophore. LC3-II acts as a recognition marker by LC3-II sensors, 
which bring cargo targeted for degradation to be sequestered to the autophagosome during its 
formation, as well as by ATG9 (shown) and other transporter proteins (not shown) which shuttle 
between various intracellular membrane compartments (e.g mitochondria, Golgi, plasma 
membrane, shown above) and transfer phospholipid fragments to be incorporated to the 
expanding structure. D. Maturation. Upon closure of the loaded phagophore, and the removal of 
the outer fraction of LC3-II, the now-complete autophagosome can then fuse with a lysosome, 
through a docking process involving Syntaxin members and the lysosomal LAMP1 and 2 
proteins, among others, to create an autolysosome, wherein its contents are degraded by 
lysosomal hydrolases, and recycled back to the intracellular space to be taken up by numerous 
effectors (not shown). 
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Figure 2 
Schematic depiction of reported effects of mammalian caspases in autophagy-related 
effectors.  
Central red arrow depicts the activation of caspases during the apoptotic cascade for the extrinsic 
and intrinsic pathway. Following activation of cell-surface expressed death receptors and DISC 
formation, pro-caspase 8 is converted to caspase-8 in ways which can also involve the 
ATG16L1-complex, and targeting of pro-caspase-8 oligomers to the autophagosomal surface by 
p62. Sequestration of pro-caspase-8 to the autophagosome can lead to caspase-8 activation, or 
downregulation, due to the extensive retention of the protease by the autophagosome, and its 
consequent degradation by lysosomal hydrolases upon autolysosome formation (not shown). It 
remains unclear whether pro-caspase-10 is regulated in a similar manner. Initiator caspase-9 is 
activated during the intrinsic pathway by cytochrome-c release from damaged mitochondria and 
the assembly of the apoptosome. The initiator caspases then cleave the pro-forms of their 
effectors, resulting in the upregulation of the executioner caspases -3, -6, and -7, altogether 
leading to the apoptotic dismantling cells. The side arrows on each caspase depict its known 
interactions with ATG targets and other autophagy-related proteins. The resulting outcome on 
autophagy is shown with an “X” over, or a “+” behind the arrows that indicate the otherwise 
physiological effect of the autophagic protein on the pathway. Alternatively the arrows may 
point towards other effectors and functions which directly impact autophagy. As shown above 
the same protein can be targeted by multiple caspases. (Not shown: Caspase-1 interactions, as it 
is a member of the inflammatory caspase group and associated mostly with the pyroptotic rather 
than the apoptotic response). 
 
 
 


 Protein Phase Main function in Autophagy 
ULK-complex 
ULK Initiation Atg1 homologues; Ser/Thr kinases that mediate mTOR signaling and upregulate downstream autophagy mediators [38]–[40] 
ATG13 Initiation ULK substrate that modulates the activity of the ULK complex [38] 
FIP200 Initiation  Atg17 homologue; ULK substrate that also modulates the activity of the ULK complex [37] 
ATG101 Initiation Interacts with ULK1 and ATG13 and protects it from degradation [41] 
PI3K-complex 
Beclin 1 
Initiation; 
Elongation; 
Maturation 
Atg6 orthologue; Part of the PI3K complex and functions on many levels during 
autophagosome assembly [43], [50] 
VPS34 Elongation; Maturation Catalytically active subunit of the PI3K complex [50] 
p150 Elongation; Maturation Vps15 orthologue; Regulatory subunit that recruits the PI3K complex to membranes [50] 
ATG14L Elongation; Maturation Atg14 orthologue; Also known as Barkor; Directs the PI3K complex to the omegasome [51] 
ATG16L1 complex 
ATG5 Elongation; Maturation 
Conjugated to ATG12 during formation of the Atg16L1 complex in autophagosome assembly 
step [16], [56] 
ATG12 Elongation; Maturation 
Ubiquitin-like protein; member of the Atg16L1 complex that aids in the activation of ATG3 
[16], [56] 
ATG16L1 Elongation; Maturation 
Atg16 homologue; Scaffold protein; Binds to the ATG5–ATG12 heterodimer and contributes 
to LC3 conjugation at the phagophore birth site [19], [56] 
Other key ATGs 
ATG3 
Elongation; 
LC3– PE 
conjugation 
E2-like conjugating enzyme; Binds LC3 to phosphatidylethanolamine on forming 
phagophore and further promotes its lipidation [56], [88] 
ATG4 Elongation; Maturation 
Atg4B most active in mammals; Cysteine protease priming LC3 for lipidation by cleaving 
carboxy-terminal Gly residues; removes LC3 from the autophagosome outer membrane 
during maturation [56], [57], [59] 
ATG7 Elongation E1-like enzyme; activates ATG12 for conjugation to Atg16L1 complex; Primes LC3 for lipidation [16], [43] 
LC3/ GABARAP/ 
GATE16,  
Elongation; 
Maturation 
The mammalian family of Atg8 homologues; ubiquitin-like proteins that are recognized in 
their lipidated form by adapter proteins bringing cargo to autophagosomes for engulfment, 
or elongation; contribute to membrane fusion; widely used markers for monitoring 
autophagy [53], [54], [56], [96] 
ATG10 Elongation E2-like enzyme; links ATG12 to ATG5 during formation of the Atg16L1 complex [43], [56]
ATG9 
Elongation; 
Membrane 
trafficking 
Atg9A and Atg9B are the mammalian Atg9 orthologues; Cargo-bearing and only 
transmembrane Atg capable of shuttling between intracellular compartments; Brings 
membrane cargo to elongating phagophore [20], [43], [50], [54] 
 
Table 1. Essential proteins in mammalian autophagy and their function in the pathway. The 
proteins listed under each complex comprise its core while the ones under “Other key ATGs” are 
central in the progress of autophagy while not necessarily belonging to a complex. The complexes 
are presented by order of their activation in the autophagic cascade (to reduce complexity, here 
nucleation has been incorporated to elongation), but they may function, along with their constituent 
proteins in more than one steps during autophagy upregulation. A short information about the main 
function of each protein in autophagy is also supplied, with mammalian homology being compared 
to the identified genes in yeast. 
 Caspase Role in Apoptosis  
(primary) 
Interactions with 
Autophagy-effectors 
Reported effect on autophagy 
Inflammatory 
Caspase-1 Involved in inflammatory 
apoptotic response during 
host-pathogen 
interactions 
LC3 (putative) 
Beclin-1 (putative) 
 
Autophagy possibly due to upregulation of LC3, and 
Beclin-1 by unidentified mechanism [67] 
 
Caspase-4 Under investigation
Caspase-5 Under investigation 
Initiators 
Caspase-2 
 
Upregulates apoptotic 
response to redox stress, 
DNA damage, heat shock, 
and cytoskeleton 
disruption; 
 
Does not process 
executioners; 
 
Substrate for both 
caspase-8 and caspase-3 
 
Controls mitochondrial 
ROS levels 
Autophagy by preventing accumulation of ROS, which 
when elevated enable dissociation of mTORC from 
autophagy initiation complex [71], [74] 
Caspase-8 
Apical caspase of extrinsic 
pathway; 
 
Cleaves target proteins 
and activates executioner 
caspases 
 
 
 
RIPK1 
 
 
p62 
 
 
ATG3 
 
ATG5 
 
Beclin-1 
 
 
Hyperactive autophagy by cleaving RIPK1, which  
normally augments autophagy. The adapter FADD binds 
to pro-caspase-8, RIPK1 and ATG5, and facilitates  
caspase-8 activation [79], [80], [86] 
 
Autophagy, depending on retention time of pro- 
caspase-8 on the autophagosome 
[83], [84]  
 
Autophagy by cleaving ATG3, ATG5, and Beclin-1 during 
autophagosome assembly. May return C-terminal  
Beclin-1 fragment with pro-apoptotic properties 
 [50], [65], [88] 
 
Caspase-9 
 
Apical caspase of intrinsic 
pathway; 
 
Activated by cyt-c and 
APAF1; 
 
Cleaves target proteins 
and activates executioner 
caspases 
 
 
ATG7 
 
 
ATG5 
 
Beclin-1 
 
 
Autophagy because caspase-9 loses catalytic activity 
when binding to ATG7, resulting in complex with higher 
affinity for LC3 than ATG7 alone [91] 
 
Autophagy by cleaving ATG5, and Beclin-1. May 
sometimes return C-terminal Beclin-1 fragment with  
pro-apoptotic properties [50], [87] 
Caspase-10 
 
Apical caspase of extrinsic 
pathway; 
 
Cleaves target proteins 
and activates executioner 
caspases 
 
ATG5 
 
Beclin-1 
 
 
BCLAF-1 
 
Autophagy by cleaving ATG5, and Beclin-1. May 
sometimes return C-terminal Beclin-1 fragment with  
pro-apoptotic properties [50], [87] 
 
Autophagy by cleaving BCLAF-1 which impairs Bcl-2-
Beclin-1 dissociation upon autophagy induction [92] 
 
Executioners 
Caspase-3 
 
Main effectors of 
initiator caspases, 
activated during both the 
extrinsic and intrinsic 
apoptotic pathway; 
 
 
Shut down cellular 
functions by cleaving 
many protein substrates 
during programmed cell 
death 
Beclin-1 
 
ATG5 
 
 
ATG4D 
 
Autophagosome 
exocytosis 
 
AMBRA-1 
 
Autophagy by cleaving ATG5 and Beclin-1. May return  
C-terminal Beclin-1 fragment with pro-apoptotic  
properties [65], [87]  
 
Autophagy by cleaving ATG4D resulting in C-terminal 
fragment with higher lipidation activity [66] 
 
Autophagy by aiding in exocytosis of autophagic 
 vesicles during apoptotic dismantling [93] 
 
Autophagy by cleaving AMBRA-1, which normally 
contributes to dissociation of Beclin-1 from Bcl-2 [52] 
 
Caspase-6 
ATG3 
 
ATG5 
 
Beclin-1 
 
p62 
 
Autophagy by cleaving p62, ATG3, ATG5, and Beclin-1. 
May sometimes return C-terminal Beclin-1 fragment 
with pro-apoptotic properties [62], [87], [90] 
Caspase-7 
ATG16L1 
 
Beclin-1 
 
Autophagy by cleaving Beclin-1, ATG16L1, and mutant  
of ATG16L1 associated with increased risk for Crohn’s 
disease. May sometimes return C-terminal Beclin-1 
fragment with pro-apoptotic properties [65], [97] 
  
 
Table 2. Effects of mammalian caspases on autophagy through their autophagy-related 
interactors. Inflammatory caspases are grouped separately, while the remaining caspases are listed 
in order of their main apoptotic function as initiators or executioners, with a brief mention of their 
role in apoptosis. Up arrows (↑) denote upregulation of autophagy as the net effect observed based 
on the described interaction, while down arrows (↓) represent downregulation of the pathway. 
